University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Emtriva

Emtriva (emtricitabine, FTC)

Type of Drug: Nucleoside Reverse Transcriptase Inhibitor

Nucleoside reverse transcriptase inhibitors were the first type of drug available to treat HIV. They are also known as NRTIs, nucleoside analogues, or "nukes."

When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.

gray line
transparent gif

Approved adult dosing

one 200 mg capsule, once a day

  • Daily

    Emtriva 200

    Emtriva

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Persons with kidney problems may need an adjustment to their dose of Emtriva
  • Do not take Emtriva with Epivir

Side effects

  • Skin discoloration (particularly in dark-skinned people)
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif